Apeloa Pharmaceutical Co.,Ltd
000739
Hisse Senetlerindeki Sıralama
#4326
Apeloa Pharmaceutical Co.,Ltd operates as a comprehensive pharmaceutical... Apeloa Pharmaceutical Co.,Ltd operates as a comprehensive pharmaceutical enterprise, specializing in the discovery, development, production, and global distribution of a diverse range of medicinal products. Its market reach spans China and various international territories. The company strategically focuses its product portfolio on several critical medical fields, including cardiovascular and cerebrovascular health, anti-infective treatments, antiviral therapies, and oncology (cancer treatment), alongside other therapeutic categories. Apeloa's offerings encompass finished pharmaceutical preparations, raw material intermediates (active pharmaceutical ingredients and their precursors), and veterinary medicines. These products are primarily recognized and sold under key brands such as Tianliwei, Beshin, Yosemade, and Jutai, among others. Furthermore, the company extends its expertise to other pharmaceutical businesses by providing contract research, development, and manufacturing (CDMO) services. The corporate headquarters for Apeloa Pharmaceutical Co.,Ltd are located in Dongyang, China.
Hisse Fiyatı
$3.11
Piyasa Değeri
$3.60B
Değişim (1 gün)
-1.94%
Değişim (1 yıl)
45.82%
Ülke
CN
Ticaret Apeloa Pharmaceutical Co.,Ltd (000739)
Kategori
Healthcare
Apeloa Pharmaceutical Co.,Ltd (000739) için P/S oranı
October 2026 itibarıyla P/S oranı TTM: 3.02
Apeloa Pharmaceutical Co.,Ltd şirketinin en son mali raporları ve hisse fiyatına göre, mevcut P/S oranı (TTM) 3.02'dir. 2023 yılının sonunda şirketin P/S oranı 1.58 idi.
Apeloa Pharmaceutical Co.,Ltd için P/S oranı geçmişi 2000 - 2026 arası
Her yılın sonunda P/S oranı
| Yıl | P/S Oranı | Değiştir |
|---|---|---|
| 2026 (TTM) | 3.02 | 92.23% |
| 2024 | 1.57 | -0.75% |
| 2023 | 1.58 | -33.91% |
| 2022 | 2.39 | -48.35% |
| 2021 | 4.62 | 32.81% |
| 2020 | 3.48 | 64.26% |
| 2019 | 2.12 | 54.78% |
| 2018 | 1.37 | 1.75% |
| 2017 | 1.35 | -25.37% |
| 2016 | 1.80 | -16.80% |
| 2015 | 2.17 | 10.98% |
| 2014 | 1.95 | 91.95% |
| 2013 | 1.02 | 118.48% |
| 2012 | 0.47 | -78.84% |
| 2011 | 2.20 | 42.46% |
| 2010 | 1.55 | -17.73% |
| 2009 | 1.88 | 119.94% |
| 2008 | 0.85 | -67.41% |
| 2007 | 2.62 | 128.30% |
| 2006 | 1.15 | 105.61% |
| 2005 | 0.56 | -31.73% |
| 2004 | 0.82 | -9.78% |
| 2003 | 0.91 | -43.62% |
| 2002 | 1.61 | -86.69% |
| 2001 | 12.08 | 16.98% |
| 2000 | 10.33 | 0.00% |
Benzer şirketler veya rakipler için P/S oranı
| Şirket | P/S Oranı | P/S Oranı Farkı | Ülke |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 7.06 | 133.86% |
IN
|
